Enables Low Temperature Synthesis of PAEK for Biomedical, Aerospace & Industrial Applications
South Windsor, CT (PRWEB) - Oxford Performance Materials, Inc. (OPM; https://oxfordpm.com/) - an industry leader in advanced polymer science, coating technologies and 3D-printed biomedical devices – announced today an agreement to acquire the patent portfolio of England’s Ketonex, Ltd., which is comprised of the world’s highest performance PAEK polymer synthesis technology. In adding these synthesis patents to its existing portfolio, OPM has furthered its capabilities as a recognized leader in PAEK (polyaryletherketone) materials technology, with broad applications in the biomedical, industrial, aerospace, energy, and electronics industries.
OPM began working with Ketonex over a decade ago. During those years the companies collaborated on the initial scale-up and development of the Ketonex polymer synthesis technologies. In early 2022 this work reached critical technical and commercial milestones, which led to the acquisition.
The Ketonex technology was built upon a low temperature PAEK synthesis method that produced high quality PAEK products. Originally commercialized by BASF, adoption was limited due to costly production methods. Ketonex subsequently improved upon existing PAEK production efficiencies and patented an advanced process. The Ketonex technology provides substantial advantages over other PAEK synthesis methods that produce materials such as PEEK and conventionally produced PEKK, as originally invented by DuPont. The patented Ketonex low temperature synthesis (“LTS”) method produces polymers with excellent stability, purity, controlled morphology, and product reproducibility. In addition, this exclusive technology portfolio enables modification of the polymer backbone to economically create new polymer systems to meet specific market and unmet commercial application demands. Specifically, this LTS technology will facilitate development of new PAEK materials with:
- Higher service temperatures for additive manufacturing of performance parts for demanding aerospace & industrial applications;
- Lower processing temperatures and improved workability that can be utilized in existing powder bed polyamide 3DP machines;
- Sustainability benefits for industries such as wind energy that face significant recycling challenges; and
- The ability to deliver advanced coating capabilities to improve carbon capture, nuclear containment, electric vehicle and other demanding energy systems.
“OPM has been working with Ketonex over many years to validate this technology and understand its potential,” said Scott DeFelice, CEO of Oxford Performance Materials. “At the outset, our groups were convinced that conventionally produced PAEK polymers had reached their limits of performance. Today’s markets are demanding improved processability and higher performance for ever-broadening material applications, and OPM will be working with industry partners that have specific applications for this unique PAEK technology.” Since its founding over 20 years ago, OPM has built a broad portfolio of IP and products that focus on PAEK application and process technologies servicing the healthcare, aerospace, energy, and electronics industries. DeFelice continued: “With the addition of the Ketonex PAEK patent portfolio, OPM has integrated back to the fundamental polymer science. This represents a capstone in our overall materials science strategy and lays the foundation for a substantial advance to the enterprise, buttressed by an integrated proprietary value chain servicing high value high growth markets.”
Terms of the transaction were not disclosed. Legal services were provided by Updike Kelly Spellacy.
About Oxford Performance Materials, Inc.
Oxford Performance Materials, Inc. was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM’s Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK® brand, including coating technologies for a range of industrial and biomedical applications. OPM is a pioneer in 3D printing. OPM’s OsteoFab® technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices, and OPM’s OXFAB® production parts are designed for highly demanding industrial applications.
About Ketonex, Ltd.
Founded in 2009, Ketonex Ltd. is a developer of proprietary synthesis methods for PAEK thermoplastics. PAEK polymers are used in highly demanding applications in industrial, biomedical, aerospace and energy markets. Developing an industrialized low temperature PAEK synthesis method is fundamental to creating enabling 21st Century materials. Ketonex has developed world class synthetic methods to modify PAEK polymers, with a focus on delivering improved material performance and processability to meet emerging market demands.